Insider Transactions in Q1 2023 at Nektar Therapeutics (NKTR)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 16
2023
|
Jonathan Zalevsky Chief R&D Officer |
SELL
Open market or private sale
|
Direct |
10,484
-3.34%
|
$31,452
$3.0 P/Share
|
|
Feb 16
2023
|
Howard W Robin President & CEO |
SELL
Open market or private sale
|
Direct |
19,635
-2.0%
|
$58,905
$3.0 P/Share
|
|
Feb 16
2023
|
Jillian B. Thomsen Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,267
-3.17%
|
$30,801
$3.0 P/Share
|
|
Feb 16
2023
|
Mark Andrew Wilson Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
8,275
-3.03%
|
$24,825
$3.0 P/Share
|